A discovery by Cornell bioengineers is shedding new light on the controversy surrounding a common treatment for osteoarthritis that has divided the medical community over its effectiveness.
Nov 25, 2015
0
15
Arthritis is the leading cause of long-term disability in Canada, with osteoarthritis being the most common form of the disease. It is estimated that 14.2 per cent of Canadians suffer from osteoarthritis.
Nov 19, 2015
0
10
(HealthDay)—For patients undergoing total knee arthroplasty (TKA) and total hip arthroplasty (THA) for osteoarthritis, the risk of myocardial infarction (MI) is increased in the first postoperative month, according to a ...
Oct 22, 2015
0
10
In anterior cruciate ligament (ACL) reconstruction, graft stiffness and pre-strain play a more vital role than the choice of surgical technique, indicates a new study from the University of Eastern Finland. The study developed ...
Oct 14, 2015
0
5
People who are lacking in vitamin D could be doubling their risk for progressive osteoarthritis, the cartilage-eroding joint disease that with age leads to achy knees and mobility problems.
Sep 18, 2015
1
26
Contrary to recent reports, Boston-based researchers found that osteoarthritis patients who had total knee or hip joint replacement surgery, known as arthroplasty, were at increased risk of heart attack (myocardial infarction) ...
Aug 31, 2015
0
17
A research team at York has adapted the astonishing capacity of animals such as newts to regenerate lost tissues and organs caused when they have a limb severed.
Aug 20, 2015
0
23
As you get older, chances are you may have noticed your knees are less forgiving when it comes to jaunting up and down the stairs. Now, a study supported in part by USDA-funded researchers suggests if you're not getting adequate ...
Jul 15, 2015
0
1060
(HealthDay)—The quality of osteoarthritis care is inadequate for all treatment domains, according to a meta-analysis published online June 17 in the Journal of Evaluation in Clinical Practice.
Jun 20, 2015
0
10
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did ...
Jun 13, 2015
0
9
